Teva touts safety profile of once monthly schizophrenia therapy
New safety data shows an absence of post-injection syndrome, a rare and serious side effect of long-acting olanzapine.
New safety data shows an absence of post-injection syndrome, a rare and serious side effect of long-acting olanzapine.
What's Your Reaction?
